LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

Home・Listă Acțiuni・Celsion Corp

Celsion Corp

Închisă

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie
By Trading Economics
Angajați	25

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+207.69% upside

Statistici piață
By TradingEconomics
Capitalizare de piață	-9.9M 938K
Deschiderea anterioară	0
Închiderea anterioară	0

Celsion Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

9 dec. 2025, 22:13 UTC

Câștiguri

GE Vernova Raises Outlook, Doubles Dividend on Energy Market Momentum

9 dec. 2025, 21:40 UTC

Câștiguri

GameStop Sales Fall as Collectibles Remain Only Bright Spot

9 dec. 2025, 18:51 UTC

Achiziții, Fuziuni, Preluări

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 dec. 2025, 16:57 UTC

Principalele dinamici ale pieței

Clear Secure Rises on Medicare Identity Verification Contract

9 dec. 2025, 23:46 UTC

Market Talk

Nikkei May Trade Rangebound Ahead of Fed Rate Decision -- Market Talk

9 dec. 2025, 23:46 UTC

Achiziții, Fuziuni, Preluări

Legend Holdings Stake in Lenovo Now at 32.34%

9 dec. 2025, 23:45 UTC

Achiziții, Fuziuni, Preluări

Legend Holdings: Remains Optimistic About Lenovo's Future Development Potential

9 dec. 2025, 23:44 UTC

Achiziții, Fuziuni, Preluări

Legend Holdings: Purchased Lenovo Shares at Average Price of HK$9.7653/Share

9 dec. 2025, 23:43 UTC

Achiziții, Fuziuni, Preluări

Legend Holdings: Acquired Lenovo Shares for Total Cash Consideration of HK$1.12B

9 dec. 2025, 23:43 UTC

Achiziții, Fuziuni, Preluări

Legend Holdings: Acquired 115.17M Lenovo Shares From Open Market Between Nov. 21 and Dec. 9

9 dec. 2025, 23:35 UTC

Market Talk

Gold Edges Higher Ahead of FOMC Decision -- Market Talk

9 dec. 2025, 22:42 UTC

Câștiguri

PepsiCo Wants to Boost Sales, Cut Costs. The Street Is Doubtful. -- Barrons.com

9 dec. 2025, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

9 dec. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 dec. 2025, 21:48 UTC

Market Talk

Hiring Confidence Slips in Canada Entering 2026 -- Market Talk

9 dec. 2025, 21:36 UTC

Câștiguri

Casey's General Stores: Fiscal 2026 EBITDA Is Expected to Increase 15% to 17% >CASY

9 dec. 2025, 21:36 UTC

Câștiguri

Casey's General Stores: Total Inside Gross Profit Increased 13.5% to $703.4M Compared to Prior Yr >CASY

9 dec. 2025, 21:36 UTC

Câștiguri

Casey's General Stores: Now Expects Inside Same-Store Sales to Increase 3% to 4% and an Inside Margin of 41% to 42% >CASY

9 dec. 2025, 21:36 UTC

Câștiguri

Casey's General Stores: Same-Store Fuel Gallons Up 0.8% Compared to Prior Yr With Fuel Margin of 41.6 Cents per Gallon, Total Fuel Gross Profit Increased 20.9% to $377.4M Compared to Prior Yr >CASY

9 dec. 2025, 21:36 UTC

Câștiguri

Casey's General Stores: Inside Same-Store Sales Increased 3.3% Compared to Prior Yr, and 7.5% on 2-Yr Stack Basis, With an Inside Margin of 42.4% >CASY

9 dec. 2025, 20:28 UTC

Market Talk

Oil Futures Decline for Second Straight Session -- Market Talk

9 dec. 2025, 20:27 UTC

Achiziții, Fuziuni, Preluări

Teck Resources: Merger of Equals With Anglo Amer Plc Approved by Both Classes of Teck Hldrs

9 dec. 2025, 20:27 UTC

Achiziții, Fuziuni, Preluări

Teck Reports Voting Results From Special Meeting of Hldrs

9 dec. 2025, 20:26 UTC

Market Talk

Achiziții, Fuziuni, Preluări

Moody's: Paramount's Warner Bid Makes Strategic Sense, With Risk -- Market Talk

9 dec. 2025, 20:21 UTC

Market Talk

U.S. Natural Gas Extends Pullback on Shifting Weather Outlook -- Market Talk

9 dec. 2025, 19:52 UTC

Câștiguri

Correction to 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com on Dec. 8

9 dec. 2025, 19:17 UTC

Câștiguri

Update: 58 S&P 500 Stocks Have Dividends Higher Than Treasuries. 10 Look Better Than Bonds. -- Barrons.com

9 dec. 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

9 dec. 2025, 17:15 UTC

Market Talk

Global Commodities Roundup: Market Talk

9 dec. 2025, 17:11 UTC

Câștiguri

Nvidia Has Permission to Sell H200 Chips to China. Why It Might Not Matter Much for the Stock. -- Barrons.com

Comparație

Modificare preț

Celsion Corp Așteptări

Obiectiv de preț

By TipRanks

207.69% sus

Prognoză pe 12 luni

Medie 12 USD 207.69%

Maxim 12 USD

Minim 12 USD

În baza a 1 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruCelsion Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

1 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 1 analiști care au acordat evaluări ale acțiunilor Celsion Corp - Dist în ultimele 3 luni.

Date financiare

Despre Celsion Corp

Imunon, Inc., a clinical-stage biotechnology company, engages in the development of immunotherapies and vaccines to treat cancer and infectious diseases. The company's lead clinical program IMNN-001, a DNA-based immunotherapy for the localized treatment of ovarian cancer that is in Phase II clinical development. Its preclinical stage products include IMNN-101, a COVID-19 booster vaccine; IMNN-102 for the treatment of Lassa virus; and IMNN-201, a Trp2 tumor associated antigen cancer vaccine in melanoma. In addition, the company develops non-viral DNA technology across four modalities, such as TheraPlas for the coding of proteins and cytokines in the treatment of solid tumors; PlaCCine for the coding of viral antigens that can elicit a strong immunological response; FixPlas for the application of Imunon's DNA technology to produce universal cancer vaccines; and IndiPlas, which is in the discovery phase for the development of personalized cancer vaccines or neoepitope cancer vaccines. Imunon, Inc. was formerly known as Celsion Corporation and changed its name to Imunon, Inc. in September 2022. The company was founded in 1982 and is headquartered in Lawrenceville, New Jersey.